News

Analysts estimate that Merck & Co will report an earnings per share (EPS) of $2.01. Investors in Merck & Co are eagerly ...
Science does not support aluminum as a culprit of autism. Yet RFK Jr. and his associates continue to find ways to support the ...
Merck has had a successful track record of beating estimates, having surpassed EPS expectations 88% of the time and beating ...
Merck & Co., Inc. (NYSE:MRK) is one of the top low volatility healthcare stocks to buy now. Analyst Daina Graybosch of ...
Few things can jolt a pharmaceutical company's shares like positive results from highly anticipated clinical trials. Even so, ...
The drugmaker has invested $10 billion in Wake and Durham counties over the past 30 years. Biogen says that figure will ...
Three critically ill patients treated with procizumab experience a full reversal of cardiogenic shock in 48 hours.
Merck is undervalued with strong growth, profitability, and credit strength despite CDMO challenges, offering compelling ...
Merck & Co., Inc. (NYSE:MRK) is included among the 11 Dogs of the Dow Dividend Stocks to Buy Now. Merck & Co., Inc. (NYSE:MRK ...
The healthcare sector, including managed-care firms and drug powerhouses, is vastly underperforming the S&P 500 index. Here ...
The deal, which will focus first on a COPD therapy GSK believes holds “best-in-class” potential, could ultimately involve a ...
Merck & Co., Inc. (NYSE:MRK) ranks among the best magic formula stocks to invest in. On July 10, UBS reiterated its Buy ...